Methods and compositions for treating conditions of the central and peripheral nervous systems using non-synaptic mechanisms
Patent 6495601 Issued on December 17, 2002. Estimated Expiration Date: December 22, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
The present invention relates to methods and compositions for treating selected conditions of the central and peripheral nervous systems employing non-synaptic mechanisms. More specifically, one aspect of the present invention relates to methods and materials for treating seizure and seizure disorders, epilepsy, status epilepticus, migraine, spreading depression, intracranial hypertension; for treating the pathophysiological effects of head trauma, stroke, ischemia and hypoxia; for treating or protecting from the pathophysiological effects of neurotoxic agents such as ethanol; and for treating neurophsyciatric disorders and central nervous system edema by administering agents that modulate ionic concentrations and/or ionic gradients in the brain, particularly ion-dependent or cation-chloride cotransporter antagonists. Ion-dependent cotransport antagonists and combinations of such compositions with other agents for treating various conditions are disclosed. The present invention also relates to methods and compositions for treating pain by administering ion-dependent cotransporter antagonists. Methods and compositions for enhancing cortical function, for example, in centers of cognition, learning and memory, by administering ion-dependent cotransporter agonists are disclosed. Methods and systems for screening drug candidate compounds for desired activities using in vitro and in vivo systems are disclosed.
Other References
"Treatment of Convulsive Ecalmpsia Crisis by Therapeutic Combination; Diazepam, Dihydralazine, Furosemide", 1971, Ngohou-Bonevat et al, Bulletin De La Federation Des Societes De Gynecologie et a D Obstertrique De Langue Francaise.
"Treatment of Hyponatraemic Seizures with Intravenos 29.2% Saline", Worthley et al, 1989, Br. Med. J, vol. 292, pp 168-170.
"Volumne-sensitive release of taurine from cultured astrocytes: properties and mechanism", Pasantes-Morales et al., 1990, Glia, 3(5), 427-32, Abstract.
Hesdorffer, D.C., et al., "Severe, Uncontrolled Hypertension and Adult-Onset Seizures: A Case-Control Study in Rochester, Minnesota," Epilepsia, vol. 37, No. 8, pp. 736-741 (1996)
Hochman, Daryl W., et al., "Dissociation of Synchronization and Excitability in Furosemide Blockade of Epileptiform Activity," Science, vol. 270, pp. 99-102 (Oct. 6, 1995)
Snow, Robert W., et al., "Electrophysiological and Optical Changes in Slice of Rat Hippocampus During Spreading Depression," Journal of Neurophysiology, vol. 50, No. 3, pp. 561-572 (Sep. 1983)
Brazil, Carl W., et al., "Advances in the Medical Treatment of Epilepsy," Annu. Rev. Med., vol. 49, pp. 135-162 (1998)
Parsons, Andrew A., "Recent Advances in Mechanisms of Spreading Depression," Current Opinion in Neurology, vol. 11, pp. 227-231 (1998)
Jaffreys, John G.R., "Mechanisms and Experimental Models of Seizure Generation," Current Opinion in Neurology, vol. 11, pp. 123-127 (1998)
Hochman, Daryl W., Ph.C., "Intrinsic Optical Changes in Neuronal Tissue," Neurosurgery Clinics of North America, vol. 8, No. 3, pp. 393-412 (Jul. 1997)
Haglund, Michael M., M.D., Ph.D., et al., "Enhanced Optical Imaging of Human Gliomas and Tumor Margins," Neurosurgery, vol. 38, No. 2, pp. 308-317 (Feb. 1996)
Haglund, Michael M., M.D., Ph.D., et al., "Enhanced Optical Imaging of Rat Gliomas and Tumor Margins," Neurosurgery, vol. 35, No. 5, pp. 930-941 (Nov. 1994)
Collins, Michael A., et al., "Brain Damage Due to Episodic Alcohol Exposure In Vivo and In Vitro: Furosemide Neuroprotection Implicates Edema-Based Mechanism," The FASEB Journal, vol. 12, pp. 221-230 (Feb. 1998)
Haglund, Michael M., et al., "Optical Imaging of Epileptiform and Functional Activity in Human Cerebral Cortex," Nature, vol. 358, pp. 668-671 (Aug. 1992)
Mathew, Ninan T., M.D., et al., "Coexistence of Migraine and Idiopathic Intracranial Hypertension Without Papilledema," Neurology, vol. 46, pp. 1226-1230 (May 1996)
Read, S.J., et al., "Furosemide Inhibits Regenerative Cortical Spreading Depression in Anaesthetized Cats," Cephalalgia, vol. 17, pp. 826-832 (1997)
Schwartzkroin, Philip A., et al., "Osmolarity, Ionic Flux, and Changes in Brain Excitability," Epilepsy Research, vol. 32, pp. 275-285 (1998)
Carter, C.H., "Status Epilepticus Treated by Intravenous Urea," Epilepsia, vol. 3, pp. 198-200 (1962)
Reed, Donal J., et al., "The Effect of Hypertonic Urea Solution on Electroshock Seizure Threshold and Eletrolyte Distribution in Rats," Reed and Woodbury, vol. 146, pp. 154-159 (1964)
Lowenstein, Daniel H., M.D., et al., "Status Epilepticus," The New England Journal of Medicine, vol. 338, No. 14, pp. 970-976 (Apr. 2, 1998)
Upton, Neil, "Mechanisms of Action of New Antiepileptic Drugs: Rational Design and Serendipitous Findings," TiPS, vol. 15, pp. 456-463 (Dec. 1994)
Macdonald, Robert L., et al., "Mechanisms of Action of New Antiepileptic Drugs," Current Opinion in Neurology, vol. 10, pp. 121-128 (1997)
Welch, K.M.A., M.D., "Pathogenesis of Migraine," Seminars in Neurology, vol. 17, No. 4, pp. 335-341 (1997)
Welch, K.M.A., M.D., "Current Opinions in Headache Pathogenesis: Introduction and Synthesis," Current Opinion in Neurology, vol. 11, pp. 193-197 (1998)
McLeod, M.S., "The Mysterious Etiology of Head Pain," Medical Sciences Bulletin, (Jul. 1996)
Welch, Mike, M.D., "Brain Imaging Studies Support Neuroelectric Etiology of Migraine Aura," Reuters Health Information, 2 pages (May 10, 1999)--Abstract
Welch, K.M., et al., "The Concept of Migraine as a State of Central Neuronal Hyperexcitability," Neural Clin., vol. 8, pp. 817-828 (1990)--Abstract
Diener, H.C., et al., "Emerging Treatments in Headache," European Neurology, vol. 38, No. 3, pp. 167-174 (1997)--Abstract
Rivera, C., et al., "The K+ /Cl- Co-Transporter KCC2 Renders GABA Hyperpolarizing During Neuronal Maturation," Nature, vol. 397, No. 6716, pp. 251-255 (Jan. 21, 1999)--Abstract
Lambert, G.A., et al., "Cortical Spreading Depression Reduces Dural Blood Flow--A Possiboe Mechanism for Migraine Pain?" Cephalagia, vol. 14., No. 6, pp. 430-436 (Dec. 1994)
Obrenovitch, T.P., et al., "Inhibition of Cortical Spreading Depression by L-701, 324, A Novel Antagonist at the Glycine Site of the N-Methyl-D-Aspartate Receptor Complex." British Journal of Pharmacology, vol. 117., No. 5, pp. 931-937 (Mar. 1997)
Welch, K.M.A., M.D., "Cortical Hyperexcitability Seen As Mechanism for Migraine With Aura," Reuters Health Information Bulletin, Jun. 20, 199
December 22, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
